|
US5223391A
(en)
*
|
1990-02-21 |
1993-06-29 |
President And Fellows Of Harvard College |
Inhibitors of herpes simplex virus replication
|
|
US5543264A
(en)
*
|
1990-06-29 |
1996-08-06 |
Associated Universities, Inc. |
Co-factor activated recombinant adenovirus proteinases
|
|
US6670188B1
(en)
*
|
1998-04-24 |
2003-12-30 |
Crucell Holland B.V. |
Packaging systems for human recombinant adenovirus to be used in gene therapy
|
|
AU2001257611A1
(en)
*
|
2000-04-28 |
2001-11-12 |
Avigen, Inc. |
Polynucleotides for use in recombinant adeno-associated virus virion production
|
|
US7754201B2
(en)
*
|
2000-06-02 |
2010-07-13 |
GenPhar, Inc |
Method of vaccination through serotype rotation
|
|
EP2336339A3
(en)
*
|
2000-09-25 |
2011-09-14 |
The Regents of the University of Michigan |
Production of viral vectors
|
|
US20040197347A1
(en)
*
|
2002-09-23 |
2004-10-07 |
Board Of Regents, The University Of Texas System |
Methods for vaccine identification and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the herpesvirus family
|
|
WO2004083418A1
(en)
*
|
2003-03-17 |
2004-09-30 |
Merck & Co., Inc. |
Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
|
|
US20050118683A1
(en)
*
|
2003-06-11 |
2005-06-02 |
Wood Clive R. |
Method for producing a polypeptide
|
|
US20080063656A1
(en)
*
|
2004-08-09 |
2008-03-13 |
Emini Emilio A |
Adenoviral Vector Compositions
|
|
CN103436507B
(zh)
*
|
2006-05-05 |
2016-04-20 |
冈戈根股份有限公司 |
噬菌体衍生的抗微生物活性剂
|
|
EP2463362B1
(en)
*
|
2007-11-28 |
2017-11-08 |
The Trustees Of The University Of Pennsylvania |
Simian subfamily c adenovirus SAdv-31 and uses thereof
|
|
WO2010115172A2
(en)
*
|
2009-04-03 |
2010-10-07 |
University Of Washington |
Antigenic peptide of hsv-2 and methods for using same
|
|
US20120171191A1
(en)
*
|
2009-05-26 |
2012-07-05 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
|
US20110293511A1
(en)
*
|
2009-09-29 |
2011-12-01 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
|
WO2018017925A1
(en)
*
|
2016-07-22 |
2018-01-25 |
President And Fellows Of Harvard College |
Targeting lytic and latent herpes simplex virus 1 infection with crispr/cas9
|
|
KR102652494B1
(ko)
*
|
2017-07-18 |
2024-03-28 |
제노비에 에이비 |
전장 t-세포 수용체 오픈 리딩 프레임의 신속한 조립 및 다양화를 위한 2-성분 벡터 라이브러리 시스템
|
|
US12370269B2
(en)
*
|
2018-03-02 |
2025-07-29 |
University Of Florida Research Foundation, Incorporated |
Retinal protective factor 2 (RPF2) protein delivered by adeno-associated virus expression
|
|
EP3784785A4
(en)
*
|
2018-04-23 |
2022-02-16 |
Duke University |
DOWNREGULATION OF SNCA EXPRESSION BY TARGETED EDITING OF DNA METHYLATION
|
|
US20210324415A1
(en)
*
|
2018-10-09 |
2021-10-21 |
Nikegen, Llc |
Compositions and methods for preparing viral vectors
|
|
GB201816919D0
(en)
*
|
2018-10-17 |
2018-11-28 |
Glaxosmithkline Ip Dev Ltd |
Adeno-associated viral vector producer cell lines
|
|
SG10201906637UA
(en)
*
|
2019-07-17 |
2021-02-25 |
Agency Science Tech & Res |
Treatment/prevention of disease by linc complex inhibition
|
|
CN114761030A
(zh)
*
|
2019-11-01 |
2022-07-15 |
休斯敦系统大学 |
具有诱导的抗肿瘤免疫的溶瘤病毒疗法
|
|
US11130787B2
(en)
*
|
2020-06-11 |
2021-09-28 |
MBF Therapeutics, Inc. |
Alphaherpesvirus glycoprotein d-encoding nucleic acid constructs and methods
|